SAS Output

BQS Organic Blind Sample Project

False Positive and Negative Report for

Method: LC9017

Analyte	TestIDCode	CASNumber	# Samples Spiked	# False Negatives	# Samples Not Spiked	# False Positives
1,7-DIMETHYLXANTHINE (P-XANTHINE)	67446LCM56	611-59-6	18	1	27	0
10-HYDROXY-AMITRIPTYLINE	67995LCM56	64520-05-4	0	0	45	0
ABACAVIR	68022LCM56	136470-78-5	18	1	27	0
ACETAMINOPHEN	67436LCM56	103-90-2	18	3	27	1
ACYCLOVIR	67484LCM56	59277-89-3	0	0	45	19
ALBUTEROL (SALBUTAMOL)	67437LCM56	18559-94-9	18	1	27	0
ALPRAZOLAM	68250LCM56	28981-97-7	10	0	35	0
AMITRIPTYLINE	67522LCM56	50-48-6	18	1	27	0
AMPHETAMINE	67461LCM56	300-62-9	8	1	37	0
ANTIPYRENE	67477LCM56	60-80-0	18	0	27	0
ATENOLOL	67502LCM56	29122-68-7	18	2	27	0
ATRAZINE	65065LCM56	1912-24-9	18	1	27	0
BENZTROPINE	67997LCM56	86-13-5	0	0	45	0
BETAMETHASONE	67485LCM56	378-44-9	18	1	27	0
BUPROPION	67439LCM56	34911-55-2	10	1	35	0
CAFFEINE	67440LCM56	58-08-2	18	0	27	2
CARBAMAZEPINE	67441LCM56	298-46-4	18	0	27	2
CARISOPRODOL	67498LCM56	78-44-4	18	1	27	0
CHLORPHENIRAMINE	67497LCM56	132-22-9	18	6	27	0
CIMETIDINE	67442LCM56	51481-61-9	18	2	27	0
CITALOPRAM	67505LCM56	59729-33-8	18	2	27	1
CLONIDINE	67518LCM56	4205-90-7	10	0	35	0
CODEINE	67443LCM56	76-57-3	8	2	37	0
COTININE	67444LCM56	486-56-6	18	3	27	2
DEHYDRONIFEDIPINE	67445LCM56	67035-22-7	18	2	27	0
DESMETHYLDILTIAZEM	67999LCM56	130606-60-9	0	0	45	5
DESVENLAFAXINE	68251LCM56	93413-62-8	18	1	27	0
DEXTROMETHORPHAN	67468LCM56	125-71-3	18	1	27	0
DIAZEPAM (VALIUM)	67499LCM56	439-14-5	10	0	35	0
DILTIAZEM	67519LCM56	42399-41-7	10	0	35	0
DIPHENHYDRAMINE	67447LCM56	147-24-0	18	2	27	0
DULOXETINE	67448LCM56	116539-59-4	0	0	45	0
ERYTHROMYCIN	67449LCM56	114-07-8	18	5	27	1
EZETIMIBE	67487LCM56	163222-33-1	18	5	27	0
FADROZOLE	68012LCM56	102676-47-1	18	1	27	0
FAMOTIDINE	68000LCM56	76824-35-6	18	5	27	0
FENOFIBRATE	67489LCM56	49562-28-9	18	2	27	0
FEXOFENADINE	67510LCM56	83799-24-0	18	1	27	0
FLUCONAZOLE	67478LCM56	86386-73-4	18	1	27	0
FLUOXETINE	67450LCM56	54910-89-3	18	1	27	0
FLUTICASONE PROPIONATE	67529LCM56	80474-14-2	18	3	27	0
FLUVOXAMINE	67521LCM56	54739-18-3	17	0	28	0
GLIPIZIDE	68001LCM56	29094-61-9	18	1	27	0
GLYBURIDE	68002LCM56	10238-21-8	18	0	27	0
HYDROCODONE	67506LCM56	125-29-1	0	0	45	0
HYDROCORTISONE	67459LCM56	50-23-7	18	1	27	0
HYDROXYZINE	68005LCM56	68-88-2	18	0	27	0
IMINOSTILBENE	67481LCM56	256-96-2	18	2	27	0
KETOCONAZOLE	68014LCM56	65277-42-1	18	1	27	0
LAMIVUDINE	68018LCM56	134678-17-4	18	5	27	0
LIDOCAINE	67462LCM56	137-58-6	18	0	27	0
LOPERAMIDE	67515LCM56	53179-11-6	10	0	35	0
LORATADINE	67488LCM56	79794-75-5	18	2	27	0
LORAZEPAM	67470LCM56	846-49-1	18	1	27	0
MEPROBAMATE	67464LCM56	57-53-4	10	0	35	0
METAXALONE	67504LCM56	1665-48-1	18	0	27	0
METFORMIN	67492LCM56	657-24-9	18	1	27	1
METHADONE	67500LCM56	76-99-3	8	1	37	0
METHOCARBAMOL	67501LCM56	532-03-6	18	4	27	0
METHOTREXATE	67525LCM56	59-05-2	18	2	27	0
METHYL-1H-BENZOTRIAZOLE	67514LCM56	29385-43-1	21	0	24	0
METOPROLOL	67523LCM56	51384-51-1	18	2	27	0
MORPHINE	67458LCM56	57-27-2	17	0	28	0
NADALOL	68006LCM56	42200-33-9	21	0	24	0
NEVIRAPINE	68017LCM56	129618-40-2	21	0	24	0
NICOTINE	67493LCM56	54-11-5	17	0	28	2
NIZATIDINE	67479LCM56	76963-41-2	17	0	28	0
NORDIAZEPAM	68252LCM56	1088-11-5	17	0	28	0
NORETHINDRONE	67434LCM56	68-22-4	21	1	24	0
NORFLUOXETINE	67451LCM56	56161-73-0	17	0	28	0
NORSERTRALINE	67532LCM56	87857-41-8	0	0	45	1
NORVERAPAMIL	68007LCM56	67018-85-3	17	0	28	0
OMEPRAZOLE + ESOMEPRAZOLE	67512LCM56	000-12-13	21	7	24	0
ORLISTAT	67490LCM56	96829-58-2	17	0	28	0
OSELTAMIVIR	67511LCM56	196618-13-0	0	0	45	0
OXAZEPAM	67469LCM56	604-75-1	17	2	28	0
OXYCODONE	67495LCM56	76-42-6	9	0	36	1
PAROXETINE	67527LCM56	61869-08-7	17	2	28	0
PENCICLOVIR	68021LCM56	39809-25-1	17	0	28	0
PENTOXIFYLLINE	67480LCM56	6493-05-6	17	0	28	0
PHENAZOPYRIDINE	68008LCM56	94-78-0	17	1	28	1
PHENDIMETRAZINE	67496LCM56	634-03-7	0	0	45	0
PHENYTOIN	67466LCM56	57-41-0	21	0	24	0
PIPERONYL BUTOXIDE	67435LCM56	51-03-6	17	1	28	0
PREDNISOLONE	67483LCM56	50-24-8	17	0	28	0
PREDNISONE	67467LCM56	53-03-2	17	0	28	0
PROMETHAZINE	67524LCM56	60-87-7	21	8	24	0
PROPOXYPHENE	68009LCM56	469-62-5	9	0	36	1
PROPRANOLOL	67516LCM56	525-66-6	21	1	24	0
PSEUDOEPHEDRINE	67460LCM56	000-12-15	9	0	36	1
QUININE	68011LCM56	130-95-0	17	0	28	0
RALOXIFENE	67530LCM56	84449-90-1	21	8	24	0
RANITIDINE	67452LCM56	66357-35-5	17	0	28	0
SERTRALINE	67528LCM56	79617-96-2	21	0	24	0
SITAGLIPTIN	67531LCM56	790712-60-6	21	1	24	0
SULFADIMETHOXINE	67503LCM56	122-11-2	21	0	24	0
SULFAMETHIZOLE	67476LCM56	144-82-1	17	0	28	0
SULFAMETHOXAZOLE	67454LCM56	723-46-6	21	2	24	0
TAMOXIFEN	68015LCM56	10540-29-1	17	8	28	0
TEMAZEPAM	67471LCM56	846-50-4	9	0	36	1
THEOPHYLLINE	67494LCM56	58-55-9	21	8	24	1
THIABENDAZOLE	67455LCM56	148-79-8	21	1	24	0
TIOTROPIUM	67508LCM56	186691-13-4	0	0	45	0
TRAMADOL	67517LCM56	27203-92-5	21	0	24	0
TRIAMTERENE	67475LCM56	396-01-0	21	1	24	0
TRIMETHOPRIM	67456LCM56	738-70-5	21	0	24	0
VALACYCLOVIR	67507LCM56	124832-26-4	21	17	24	0
VENLAFAXINE	67534LCM56	93413-69-5	21	2	24	0
VERAPAMIL	67472LCM56	52-53-9	21	0	24	0
WARFARIN	67457LCM56	81-81-2	21	3	24	1

BQS Organic Blind Sample Program

False Positives & False Negatives

1,7-DIMETHYLXANTHINE (P-XANTHINE)

Method: LC9017 Testid: 67446LCM56

Link to Individual Chart

False Positive & Negative Listing for 1,7-DIMETHYLXANTHINE (P-XANTHINE)

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20120960120	ERA 0823-11-05.1: 20 µl	87.7	04/10/12	< 152	178

Updated 08/31/2015

BQS Organic Blind Sample Program

False Positives & False Negatives

ABACAVIR

Method: LC9017 Testid: 68022LCM56

Link to Individual Chart

False Positive & Negative Listing for ABACAVIR

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20123560094	Abs 053112: 40 µl & ERA 0507-12-06.2: 40 µl	8.21	01/24/13	< 8.21	33

Updated 08/31/2015

BQS Organic Blind Sample Program

False Positives & False Negatives

ACETAMINOPHEN

Method: LC9017 Testid: 67436LCM56

Link to Individual Chart

False Positive & Negative Listing for ACETAMINOPHEN

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20120960120	ERA 0823-11-05.1: 20 µl	7.13	04/10/12	< 10	14.45
	20122930153	Abs 060112: 10 µl & Spex Organics T1120802015: 10 µl	7.13	10/25/12	< 7.13	7.5
	20133110111	ERA 0823-11-05.1: 15 µl & Abs 071112: 15 µl	7.13	11/20/13	< 8.48	10.8375
False Positive	20123140091	Abs 071112: 40 µl & ERA 0507-12-06.1: 40 µl	7.13	11/20/12	. 26.4	0

Updated 08/31/2015

BQS Organic Blind Sample Program

False Positives & False Negatives

ACYCLOVIR

Method: LC9017 Testid: 67484LCM56

Link to Individual Chart

False Positive & Negative Listing for ACYCLOVIR

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.
False Positive	20121040015	ERA 0823-11-05.2: 20 µl	22.2	05/01/12	. 102
	20121390010	ERA 0823-11-05.2: 40 µl	22.2	06/15/12	. 199
	20121600153	ERA 0823-11-05.2: 10 µl	22.2	06/15/12	. 44.4
	20122020003	ERA 0823-11-05.2: 20 µl	22.2	07/26/12	. 150
	20122500212	Spex Organics T1120802015: 20 µl & Abs 071112: 20 µl	22.2	09/27/12	. 53.1
	20123140091	Abs 071112: 40 µl & ERA 0507-12-06.1: 40 µl	22.2	11/20/12	. 183
	20123420072	Abs 071112: 10 µl & ERA 0507-12-06.2: 10 µl	22.2	12/14/12	. 34.8
	20130320040	ERA 0823-11-05.2: 10 µl & Abs 053112: 10 µl	22.2	02/28/13	. 32.5
	20130390106	Spex Organics T1120802015: 20 µl & Abs 071112: 20 µl	22.2	02/28/13	. 66.2
	20131090003	Abs 071112: 20 µl & ERA 0507-12-06.2: 20 µl	22.2	04/26/13	. 84.3
	20131210057	Abs 071112: 40 µl	22.2	05/03/13	. 131
	20131210059	ERA 0823-11-05.2: 40 µl	22.2	05/03/13	. 161
	20132070033	ERA 0823-11-05.2: 15 µl & ERA 0507-12-06.1: 15 µl	22.2	08/02/13	. 104
	20133110111	ERA 0823-11-05.1: 15 µl & Abs 071112: 15 µl	22.2	11/20/13	. 62.1
	20133310033	Abs 071112: 20 µl & Abs 053112: 20 µl	22.2	12/05/13	. 82.3
	20140030015	Abs 071112: 20 µl & ERA 0507-12-06.2: 20 µl	22.2	01/16/14	E 53.4
	20140300038	Spex Organics T1120802015: 20 µl & Abs 071112: 20 µl	22.2	02/20/14	. 71.9
	20140370080	ERA 0823-11-05.2: 20 µl & Abs 053112: 20 µl	22.2	02/20/14	. 95.1
	20140860101	Abs 071112: 20 µl & Abs 060112: 20 µl	22.2	04/10/14	. 50.4

Updated 08/31/2015

BQS Organic Blind Sample Program

False Positives & False Negatives

ALBUTEROL (SALBUTAMOL)

Method: LC9017 Testid: 67437LCM56

Link to Individual Chart

False Positive & Negative Listing for ALBUTEROL (SALBUTAMOL)

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20120960120	ERA 0823-11-05.1: 20 µl	6.06	04/10/12	< 6.06	12.05

Updated 08/31/2015

BQS Organic Blind Sample Program

False Positives & False Negatives

AMITRIPTYLINE

Method: LC9017 Testid: 67522LCM56

Link to Individual Chart

False Positive & Negative Listing for AMITRIPTYLINE

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20123560094	Abs 053112: 40 µl & ERA 0507-12-06.2: 40 µl	37.2	01/24/13	< 37.2	150

Updated 08/31/2015

BQS Organic Blind Sample Program

False Positives & False Negatives

AMPHETAMINE

Method: LC9017 Testid: 67461LCM56

Link to Individual Chart

False Positive & Negative Listing for AMPHETAMINE

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20123560094	Abs 053112: 40 µl & ERA 0507-12-06.2: 40 µl	8.14	01/24/13	< 8.14	33

Updated 08/31/2015

BQS Organic Blind Sample Program

False Positives & False Negatives

ATENOLOL

Method: LC9017 Testid: 67502LCM56

Link to Individual Chart

False Positive & Negative Listing for ATENOLOL

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20133110111	ERA 0823-11-05.1: 15 µl & Abs 071112: 15 µl	13.3	11/20/13	< 13.3	20.025
	20140160086	ERA 0823-11-05.1: 15 µl & Abs 053112: 15 µl	13.3	02/19/14	< 13.3	20.025

Updated 08/31/2015

BQS Organic Blind Sample Program

False Positives & False Negatives

ATRAZINE

Method: LC9017 Testid: 65065LCM56

Link to Individual Chart

False Positive & Negative Listing for ATRAZINE

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20122930153	Abs 060112: 10 µl & Spex Organics T1120802015: 10 µl	19.4	10/25/12	< 19.4	20

Updated 08/31/2015

BQS Organic Blind Sample Program

False Positives & False Negatives

BETAMETHASONE

Method: LC9017 Testid: 67485LCM56

Link to Individual Chart

False Positive & Negative Listing for BETAMETHASONE

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20123560094	Abs 053112: 40 µl & ERA 0507-12-06.2: 40 µl	114	01/24/13	< 114	458

Updated 08/31/2015

BQS Organic Blind Sample Program

False Positives & False Negatives

BUPROPION

Method: LC9017 Testid: 67439LCM56

Link to Individual Chart

False Positive & Negative Listing for BUPROPION

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20131210053	ERA 0823-11-05.1: 40 µl	17.8	05/02/13	< 27.9	73.3

Updated 08/31/2015

BQS Organic Blind Sample Program

False Positives & False Negatives

CAFFEINE

Method: LC9017 Testid: 67440LCM56

Link to Individual Chart

False Positive & Negative Listing for CAFFEINE

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Positive	20123420072	Abs 071112: 10 µl & ERA 0507-12-06.2: 10 µl	90.7	12/14/12	. 5.5	0
	20133310033	Abs 071112: 20 µl & Abs 053112: 20 µl	90.7	12/05/13	. 23.1	0

Updated 08/31/2015

BQS Organic Blind Sample Program

False Positives & False Negatives

CARBAMAZEPINE

Method: LC9017 Testid: 67441LCM56

Link to Individual Chart

False Positive & Negative Listing for CARBAMAZEPINE

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Positive	20131210054	ERA 0507-12-06.1: 40 µl	4.18	05/02/13	. 0.72	0
	20131210060	Abs 053112: 40 µl	4.18	05/03/13	. 0.87	0

Updated 08/31/2015

BQS Organic Blind Sample Program

False Positives & False Negatives

CARISOPRODOL

Method: LC9017 Testid: 67498LCM56

Link to Individual Chart

False Positive & Negative Listing for CARISOPRODOL

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20140160086	ERA 0823-11-05.1: 15 µl & Abs 053112: 15 µl	12.5	02/19/14	< 17.9	18.9

Updated 08/31/2015

BQS Organic Blind Sample Program

False Positives & False Negatives

CHLORPHENIRAMINE

Method: LC9017 Testid: 67497LCM56

Link to Individual Chart

False Positive & Negative Listing for CHLORPHENIRAMINE

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20122720046	Abs 053112: 20 µl & ERA 0507-12-06.2: 20 µl	4.68	10/25/12	< 4.68	9.5
	20123560094	Abs 053112: 40 µl & ERA 0507-12-06.2: 40 µl	4.68	01/24/13	< 4.68	19
	20132210043	ERA 0507-12-06.1: 15 µl & Abs 060112: 15 µl	4.68	08/18/13	< 4.68	7.125
	20133310033	Abs 071112: 20 µl & Abs 053112: 20 µl	4.68	12/05/13	< 4.68	9.5
	20140160086	ERA 0823-11-05.1: 15 µl & Abs 053112: 15 µl	4.68	02/19/14	< 4.68	7.125
	20140510045	ERA 0507-12-06.1: 20 µl & ERA 0507-12-06.2: 20 µl	4.68	03/21/14	< 4.68	9.5

Updated 08/31/2015

BQS Organic Blind Sample Program

False Positives & False Negatives

CIMETIDINE

Method: LC9017 Testid: 67442LCM56

Link to Individual Chart

False Positive & Negative Listing for CIMETIDINE

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20140160086	ERA 0823-11-05.1: 15 µl & Abs 053112: 15 µl	27.8	02/19/14	< 27.8	41.25
	20140300038	Spex Organics T1120802015: 20 µl & Abs 071112: 20 µl	27.8	02/20/14	< 27.8	55

Updated 08/31/2015

BQS Organic Blind Sample Program

False Positives & False Negatives

CITALOPRAM

Method: LC9017 Testid: 67505LCM56

Link to Individual Chart

False Positive & Negative Listing for CITALOPRAM

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20123560094	Abs 053112: 40 µl & ERA 0507-12-06.2: 40 µl	6.58	01/24/13	< 6.58	26
	20130740022	Abs 053112: 20 µl & Abs 060112: 20 µl	6.58	03/27/13	< 6.58	13
False Positive	20121600153	ERA 0823-11-05.2: 10 µl	6.58	06/15/12	. 4.7	0

Updated 08/31/2015

BQS Organic Blind Sample Program

False Positives & False Negatives

CODEINE

Method: LC9017 Testid: 67443LCM56

Link to Individual Chart

False Positive & Negative Listing for CODEINE

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20123560094	Abs 053112: 40 µl & ERA 0507-12-06.2: 40 µl	88.3	01/24/13	< 88.3	355
	20133310033	Abs 071112: 20 µl & Abs 053112: 20 µl	88.3	12/05/13	< 88.3	177.5

Updated 08/31/2015

BQS Organic Blind Sample Program

False Positives & False Negatives

COTININE

Method: LC9017 Testid: 67444LCM56

Link to Individual Chart

False Positive & Negative Listing for COTININE

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20120960120	ERA 0823-11-05.1: 20 µl	6.37	04/10/12	< 6.47	12.75
	20121460094	ERA 0823-11-05.1: 10 µl	6.37	06/15/12	< 6.37	6.375
	20122930153	Abs 060112: 10 µl & Spex Organics T1120802015: 10 µl	6.37	10/25/12	< 6.37	7.5
False Positive	20123560094	Abs 053112: 40 µl & ERA 0507-12-06.2: 40 µl	6.37	01/24/13	. 2	0
	20131210060	Abs 053112: 40 µl	6.37	05/03/13	. 2.36	0

Updated 08/31/2015

BQS Organic Blind Sample Program

False Positives & False Negatives

DEHYDRONIFEDIPINE

Method: LC9017 Testid: 67445LCM56

Link to Individual Chart

False Positive & Negative Listing for DEHYDRONIFEDIPINE

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20122720046	Abs 053112: 20 µl & ERA 0507-12-06.2: 20 µl	24.5	10/25/12	< 48.9	49.5
	20123560094	Abs 053112: 40 µl & ERA 0507-12-06.2: 40 µl	24.5	01/24/13	< 24.5	99

Updated 08/31/2015

BQS Organic Blind Sample Program

False Positives & False Negatives

DESMETHYLDILTIAZEM

Method: LC9017 Testid: 67999LCM56

Link to Individual Chart

False Positive & Negative Listing for DESMETHYLDILTIAZEM

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.
False Positive	20131210058	Spex Organics T1120802015: 40 µl	12.4	05/03/13	E 0.75
	20131210059	ERA 0823-11-05.2: 40 µl	12.4	05/03/13	E 0.85
	20131210060	Abs 053112: 40 µl	12.4	05/03/13	E 0.74
	20132340083	Spex Organics T1120802015: 20 µl & ERA 0507-12-06.1: 20 µl	12.4	08/29/13	E 3.26
	20140780046	ERA 0823-11-05.1: 20 µl & ERA 0507-12-06.1: 20 µl	12.4	03/21/14	E 3.79

Updated 08/31/2015

BQS Organic Blind Sample Program

False Positives & False Negatives

DESVENLAFAXINE

Method: LC9017 Testid: 68251LCM56

Link to Individual Chart

False Positive & Negative Listing for DESVENLAFAXINE

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20123560094	Abs 053112: 40 µl & ERA 0507-12-06.2: 40 µl	7.49	01/24/13	< 7.49	30

Updated 08/31/2015

BQS Organic Blind Sample Program

False Positives & False Negatives

DEXTROMETHORPHAN

Method: LC9017 Testid: 67468LCM56

Link to Individual Chart

False Positive & Negative Listing for DEXTROMETHORPHAN

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20123560094	Abs 053112: 40 µl & ERA 0507-12-06.2: 40 µl	8.2	01/24/13	< 8.2	33

Updated 08/31/2015

BQS Organic Blind Sample Program

False Positives & False Negatives

DIPHENHYDRAMINE

Method: LC9017 Testid: 67447LCM56

Link to Individual Chart

False Positive & Negative Listing for DIPHENHYDRAMINE

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20123560094	Abs 053112: 40 µl & ERA 0507-12-06.2: 40 µl	5.79	01/24/13	< 5.79	23
	20133310033	Abs 071112: 20 µl & Abs 053112: 20 µl	5.79	12/05/13	< 5.79	11.5

Updated 08/31/2015

BQS Organic Blind Sample Program

False Positives & False Negatives

ERYTHROMYCIN

Method: LC9017 Testid: 67449LCM56

Link to Individual Chart

False Positive & Negative Listing for ERYTHROMYCIN

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20123560094	Abs 053112: 40 µl & ERA 0507-12-06.2: 40 µl	53.1	01/24/13	< 53.1	213
	20130740022	Abs 053112: 20 µl & Abs 060112: 20 µl	53.1	03/27/13	< 53.1	106.5
	20132340083	Spex Organics T1120802015: 20 µl & ERA 0507-12-06.1: 20 µl	53.1	08/29/13	< 53.1	106.5
	20140510045	ERA 0507-12-06.1: 20 µl & ERA 0507-12-06.2: 20 µl	53.1	03/21/14	< 53.1	106.5
	20140780046	ERA 0823-11-05.1: 20 µl & ERA 0507-12-06.1: 20 µl	53.1	03/21/14	< 53.1	106.5
False Positive	20121810009	ERA 0823-11-05.1: 20 µl	53.1	07/26/12	. 5.77	0

Updated 08/31/2015

BQS Organic Blind Sample Program

False Positives & False Negatives

EZETIMIBE

Method: LC9017 Testid: 67487LCM56

Link to Individual Chart

False Positive & Negative Listing for EZETIMIBE

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20120960120	ERA 0823-11-05.1: 20 µl	63.5	04/10/12	< 63.5	128
	20121460094	ERA 0823-11-05.1: 10 µl	63.5	06/15/12	< 63.5	64
	20130390106	Spex Organics T1120802015: 20 µl & Abs 071112: 20 µl	63.5	02/28/13	< 63.5	125
	20133110111	ERA 0823-11-05.1: 15 µl & Abs 071112: 15 µl	63.5	11/20/13	< 63.5	96
	20140780046	ERA 0823-11-05.1: 20 µl & ERA 0507-12-06.1: 20 µl	63.5	03/21/14	< 80	128

Updated 08/31/2015

BQS Organic Blind Sample Program

False Positives & False Negatives

FADROZOLE

Method: LC9017 Testid: 68012LCM56

Link to Individual Chart

False Positive & Negative Listing for FADROZOLE

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20123560094	Abs 053112: 40 µl & ERA 0507-12-06.2: 40 µl	7.32	01/24/13	< 7.32	29

Updated 08/31/2015

BQS Organic Blind Sample Program

False Positives & False Negatives

FAMOTIDINE

Method: LC9017 Testid: 68000LCM56

Link to Individual Chart

False Positive & Negative Listing for FAMOTIDINE

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20122720046	Abs 053112: 20 µl & ERA 0507-12-06.2: 20 µl	10.7	10/25/12	< 10.7	21.5
	20123560094	Abs 053112: 40 µl & ERA 0507-12-06.2: 40 µl	10.7	01/24/13	< 10.7	43
	20130320040	ERA 0823-11-05.2: 10 µl & Abs 053112: 10 µl	10.7	02/28/13	< 10.7	10.75
	20130740022	Abs 053112: 20 µl & Abs 060112: 20 µl	10.7	03/27/13	< 10.7	21.5
	20133310033	Abs 071112: 20 µl & Abs 053112: 20 µl	10.7	12/05/13	< 10.7	21.5

Updated 08/31/2015

BQS Organic Blind Sample Program

False Positives & False Negatives

FENOFIBRATE

Method: LC9017 Testid: 67489LCM56

Link to Individual Chart

False Positive & Negative Listing for FENOFIBRATE

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20122930153	Abs 060112: 10 µl & Spex Organics T1120802015: 10 µl	6.28	10/25/12	< 6.28	7.5
	20140780046	ERA 0823-11-05.1: 20 µl & ERA 0507-12-06.1: 20 µl	6.28	03/21/14	< 6.28	12.75

Updated 08/31/2015

BQS Organic Blind Sample Program

False Positives & False Negatives

FEXOFENADINE

Method: LC9017 Testid: 67510LCM56

Link to Individual Chart

False Positive & Negative Listing for FEXOFENADINE

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20140160086	ERA 0823-11-05.1: 15 µl & Abs 053112: 15 µl	19.9	02/19/14	< 19.9	29.5125

Updated 08/31/2015

BQS Organic Blind Sample Program

False Positives & False Negatives

FLUCONAZOLE

Method: LC9017 Testid: 67478LCM56

Link to Individual Chart

False Positive & Negative Listing for FLUCONAZOLE

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20123560094	Abs 053112: 40 µl & ERA 0507-12-06.2: 40 µl	71	01/24/13	< 71	285

Updated 08/31/2015

BQS Organic Blind Sample Program

False Positives & False Negatives

FLUOXETINE

Method: LC9017 Testid: 67450LCM56

Link to Individual Chart

False Positive & Negative Listing for FLUOXETINE

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20140160086	ERA 0823-11-05.1: 15 µl & Abs 053112: 15 µl	26.9	02/19/14	< 26.9	40.125

Updated 08/31/2015

BQS Organic Blind Sample Program

False Positives & False Negatives

FLUTICASONE PROPIONATE

Method: LC9017 Testid: 67529LCM56

Link to Individual Chart

False Positive & Negative Listing for FLUTICASONE PROPIONATE

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20122230019	Abs 060112: 20 µl & ERA 0507-12-06.1: 20 µl	4.62	08/15/12	< 4.62	8.9
	20123560094	Abs 053112: 40 µl & ERA 0507-12-06.2: 40 µl	4.62	01/24/13	< 4.62	18
	20132070033	ERA 0823-11-05.2: 15 µl & ERA 0507-12-06.1: 15 µl	4.62	08/02/13	< 4.62	6.675

Updated 08/31/2015

BQS Organic Blind Sample Program

False Positives & False Negatives

GLIPIZIDE

Method: LC9017 Testid: 68001LCM56

Link to Individual Chart

False Positive & Negative Listing for GLIPIZIDE

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20123560094	Abs 053112: 40 µl & ERA 0507-12-06.2: 40 µl	34.6	01/24/13	< 34.6	138

Updated 08/31/2015

BQS Organic Blind Sample Program

False Positives & False Negatives

HYDROCORTISONE

Method: LC9017 Testid: 67459LCM56

Link to Individual Chart

False Positive & Negative Listing for HYDROCORTISONE

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20123560094	Abs 053112: 40 µl & ERA 0507-12-06.2: 40 µl	147	01/24/13	< 147	591

Updated 08/31/2015

BQS Organic Blind Sample Program

False Positives & False Negatives

IMINOSTILBENE

Method: LC9017 Testid: 67481LCM56

Link to Individual Chart

False Positive & Negative Listing for IMINOSTILBENE

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20123560094	Abs 053112: 40 µl & ERA 0507-12-06.2: 40 µl	145	01/24/13	< 145	581
	20132340083	Spex Organics T1120802015: 20 µl & ERA 0507-12-06.1: 20 µl	145	08/29/13	< 145	289

Updated 08/31/2015

BQS Organic Blind Sample Program

False Positives & False Negatives

KETOCONAZOLE

Method: LC9017 Testid: 68014LCM56

Link to Individual Chart

False Positive & Negative Listing for KETOCONAZOLE

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20123560094	Abs 053112: 40 µl & ERA 0507-12-06.2: 40 µl	113	01/24/13	< 113	453

Updated 08/31/2015

BQS Organic Blind Sample Program

False Positives & False Negatives

LAMIVUDINE

Method: LC9017 Testid: 68018LCM56

Link to Individual Chart

False Positive & Negative Listing for LAMIVUDINE

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20122720046	Abs 053112: 20 µl & ERA 0507-12-06.2: 20 µl	16.1	10/25/12	< 16.1	32
	20123560094	Abs 053112: 40 µl & ERA 0507-12-06.2: 40 µl	16.1	01/24/13	< 16.1	64
	20130740022	Abs 053112: 20 µl & Abs 060112: 20 µl	16.1	03/27/13	< 16.1	32
	20133310033	Abs 071112: 20 µl & Abs 053112: 20 µl	16.1	12/05/13	< 16.1	32
	20140160086	ERA 0823-11-05.1: 15 µl & Abs 053112: 15 µl	16.1	02/19/14	< 16.1	24

Updated 08/31/2015

BQS Organic Blind Sample Program

False Positives & False Negatives

LORATADINE

Method: LC9017 Testid: 67488LCM56

Link to Individual Chart

False Positive & Negative Listing for LORATADINE

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20123560094	Abs 053112: 40 µl & ERA 0507-12-06.2: 40 µl	6.95	01/24/13	< 6.95	28
	20130320040	ERA 0823-11-05.2: 10 µl & Abs 053112: 10 µl	6.95	02/28/13	< 6.95	7

Updated 08/31/2015

BQS Organic Blind Sample Program

False Positives & False Negatives

LORAZEPAM

Method: LC9017 Testid: 67470LCM56

Link to Individual Chart

False Positive & Negative Listing for LORAZEPAM

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20123560094	Abs 053112: 40 µl & ERA 0507-12-06.2: 40 µl	116	01/24/13	< 116	466

Updated 08/31/2015

BQS Organic Blind Sample Program

False Positives & False Negatives

METFORMIN

Method: LC9017 Testid: 67492LCM56

Link to Individual Chart

False Positive & Negative Listing for METFORMIN

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20132340083	Spex Organics T1120802015: 20 µl & ERA 0507-12-06.1: 20 µl	13.1	08/29/13	< 13.1	25
False Positive	20123140091	Abs 071112: 40 µl & ERA 0507-12-06.1: 40 µl	13.1	11/20/12	. 5.96	0

Updated 08/31/2015

BQS Organic Blind Sample Program

False Positives & False Negatives

METHADONE

Method: LC9017 Testid: 67500LCM56

Link to Individual Chart

False Positive & Negative Listing for METHADONE

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20123560094	Abs 053112: 40 µl & ERA 0507-12-06.2: 40 µl	7.61	01/24/13	< 7.61	30

Updated 08/31/2015

BQS Organic Blind Sample Program

False Positives & False Negatives

METHOCARBAMOL

Method: LC9017 Testid: 67501LCM56

Link to Individual Chart

False Positive & Negative Listing for METHOCARBAMOL

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20120960120	ERA 0823-11-05.1: 20 µl	8.72	04/10/12	< 8.72	17.75
	20133470009	ERA 0823-11-05.1: 15 µl & Abs 060112: 15 µl	8.72	01/16/14	< 9.75	13.3125
	20140160086	ERA 0823-11-05.1: 15 µl & Abs 053112: 15 µl	8.72	02/19/14	< 10.6	13.3125
	20140300038	Spex Organics T1120802015: 20 µl & Abs 071112: 20 µl	8.72	02/20/14	< 18.7	20

Updated 08/31/2015

BQS Organic Blind Sample Program

False Positives & False Negatives

METHOTREXATE

Method: LC9017 Testid: 67525LCM56

Link to Individual Chart

False Positive & Negative Listing for METHOTREXATE

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20123560094	Abs 053112: 40 µl & ERA 0507-12-06.2: 40 µl	52.4	01/24/13	< 52.4	210
	20140160086	ERA 0823-11-05.1: 15 µl & Abs 053112: 15 µl	52.4	02/19/14	< 52.4	78.75

Updated 08/31/2015

BQS Organic Blind Sample Program

False Positives & False Negatives

METOPROLOL

Method: LC9017 Testid: 67523LCM56

Link to Individual Chart

False Positive & Negative Listing for METOPROLOL

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20123560094	Abs 053112: 40 µl & ERA 0507-12-06.2: 40 µl	27.5	01/24/13	< 27.5	110
	20132070033	ERA 0823-11-05.2: 15 µl & ERA 0507-12-06.1: 15 µl	27.5	08/02/13	< 27.5	42

Updated 08/31/2015

BQS Organic Blind Sample Program

False Positives & False Negatives

NICOTINE

Method: LC9017 Testid: 67493LCM56

Link to Individual Chart

False Positive & Negative Listing for NICOTINE

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Positive	20131210058	Spex Organics T1120802015: 40 µl	57.8	05/03/13	. 6.99	0
	20131210060	Abs 053112: 40 µl	57.8	05/03/13	. 20.7	0

Updated 08/31/2015

BQS Organic Blind Sample Program

False Positives & False Negatives

NORETHINDRONE

Method: LC9017 Testid: 67434LCM56

Link to Individual Chart

False Positive & Negative Listing for NORETHINDRONE

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20140370080	ERA 0823-11-05.2: 20 µl & Abs 053112: 20 µl	10.9	02/20/14	< 10.9	22.15

Updated 08/31/2015

BQS Organic Blind Sample Program

False Positives & False Negatives

NORSERTRALINE

Method: LC9017 Testid: 67532LCM56

Link to Individual Chart

False Positive & Negative Listing for NORSERTRALINE

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Positive	20123420072	Abs 071112: 10 µl & ERA 0507-12-06.2: 10 µl	192	12/14/12	E 5.71	0

Updated 08/31/2015

BQS Organic Blind Sample Program

False Positives & False Negatives

OMEPRAZOLE + ESOMEPRAZOLE

Method: LC9017 Testid: 67512LCM56

Link to Individual Chart

False Positive & Negative Listing for OMEPRAZOLE + ESOMEPRAZOLE

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20121600153	ERA 0823-11-05.2: 10 µl	5.62	06/15/12	< 5.62	5.675
	20130320040	ERA 0823-11-05.2: 10 µl & Abs 053112: 10 µl	5.62	02/28/13	< 5.62	5.675
	20130390106	Spex Organics T1120802015: 20 µl & Abs 071112: 20 µl	5.62	02/28/13	< 5.62	11
	20132070033	ERA 0823-11-05.2: 15 µl & ERA 0507-12-06.1: 15 µl	5.62	08/02/13	< 5.62	8.512501
	20132630004	ERA 0823-11-05.2: 15 µl & Abs 060112: 15 µl	5.62	10/29/13	< 5.62	8.512501
	20133310033	Abs 071112: 20 µl & Abs 053112: 20 µl	5.62	12/05/13	< 10	11
	20140370080	ERA 0823-11-05.2: 20 µl & Abs 053112: 20 µl	5.62	02/20/14	< 5.62	11.35

Updated 08/31/2015

BQS Organic Blind Sample Program

False Positives & False Negatives

OXAZEPAM

Method: LC9017 Testid: 67469LCM56

Link to Individual Chart

False Positive & Negative Listing for OXAZEPAM

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20122930153	Abs 060112: 10 µl & Spex Organics T1120802015: 10 µl	140	10/25/12	< 140	140.75
	20123420072	Abs 071112: 10 µl & ERA 0507-12-06.2: 10 µl	140	12/14/12	< 140	141.25

Updated 08/31/2015

BQS Organic Blind Sample Program

False Positives & False Negatives

OXYCODONE

Method: LC9017 Testid: 67495LCM56

Link to Individual Chart

False Positive & Negative Listing for OXYCODONE

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Positive	20123560094	Abs 053112: 40 µl & ERA 0507-12-06.2: 40 µl	24.9	01/24/13	. 80.6	0

Updated 08/31/2015

BQS Organic Blind Sample Program

False Positives & False Negatives

PAROXETINE

Method: LC9017 Testid: 67527LCM56

Link to Individual Chart

False Positive & Negative Listing for PAROXETINE

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20130740022	Abs 053112: 20 µl & Abs 060112: 20 µl	20.6	03/27/13	< 20.6	41
	20132630004	ERA 0823-11-05.2: 15 µl & Abs 060112: 15 µl	20.6	10/29/13	< 20.6	30.75

Updated 08/31/2015

BQS Organic Blind Sample Program

False Positives & False Negatives

PHENAZOPYRIDINE

Method: LC9017 Testid: 68008LCM56

Link to Individual Chart

False Positive & Negative Listing for PHENAZOPYRIDINE

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20131090003	Abs 071112: 20 µl & ERA 0507-12-06.2: 20 µl	13.3	04/26/13	< 13.3	26.35
False Positive	20121810009	ERA 0823-11-05.1: 20 µl	13.3	07/26/12	. 0.43	0

Updated 08/31/2015

BQS Organic Blind Sample Program

False Positives & False Negatives

PIPERONYL BUTOXIDE

Method: LC9017 Testid: 67435LCM56

Link to Individual Chart

False Positive & Negative Listing for PIPERONYL BUTOXIDE

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20122230019	Abs 060112: 20 µl & ERA 0507-12-06.1: 20 µl	3.07	08/15/12	< 3.07	6

Updated 08/31/2015

BQS Organic Blind Sample Program

False Positives & False Negatives

PROMETHAZINE

Method: LC9017 Testid: 67524LCM56

Link to Individual Chart

False Positive & Negative Listing for PROMETHAZINE

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20121040015	ERA 0823-11-05.2: 20 µl	50	05/01/12	< 50	101
	20123420072	Abs 071112: 10 µl & ERA 0507-12-06.2: 10 µl	50	12/14/12	< 50	50.25
	20130320040	ERA 0823-11-05.2: 10 µl & Abs 053112: 10 µl	50	02/28/13	< 50	50.5
	20131090003	Abs 071112: 20 µl & ERA 0507-12-06.2: 20 µl	50	04/26/13	< 50	100.5
	20131210059	ERA 0823-11-05.2: 40 µl	50	05/03/13	< 50	202
	20132070033	ERA 0823-11-05.2: 15 µl & ERA 0507-12-06.1: 15 µl	50	08/02/13	< 50	75.75
	20132630004	ERA 0823-11-05.2: 15 µl & Abs 060112: 15 µl	50	10/29/13	< 50	75.75
	20140370080	ERA 0823-11-05.2: 20 µl & Abs 053112: 20 µl	50	02/20/14	< 50	101

Updated 08/31/2015

BQS Organic Blind Sample Program

False Positives & False Negatives

PROPOXYPHENE

Method: LC9017 Testid: 68009LCM56

Link to Individual Chart

False Positive & Negative Listing for PROPOXYPHENE

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Positive	20123560094	Abs 053112: 40 µl & ERA 0507-12-06.2: 40 µl	17.2	01/24/13	. 46.3	0

Updated 08/31/2015

BQS Organic Blind Sample Program

False Positives & False Negatives

PROPRANOLOL

Method: LC9017 Testid: 67516LCM56

Link to Individual Chart

False Positive & Negative Listing for PROPRANOLOL

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20122500212	Spex Organics T1120802015: 20 µl & Abs 071112: 20 µl	26.3	09/27/12	< 40	53.5

Updated 08/31/2015

BQS Organic Blind Sample Program

False Positives & False Negatives

PSEUDOEPHEDRINE

Method: LC9017 Testid: 67460LCM56

Link to Individual Chart

False Positive & Negative Listing for PSEUDOEPHEDRINE

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Positive	20123560094	Abs 053112: 40 µl & ERA 0507-12-06.2: 40 µl	11.1	01/24/13	. 36	0

Updated 08/31/2015

BQS Organic Blind Sample Program

False Positives & False Negatives

RALOXIFENE

Method: LC9017 Testid: 67530LCM56

Link to Individual Chart

False Positive & Negative Listing for RALOXIFENE

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20121390010	ERA 0823-11-05.2: 40 µl	9.72	06/15/12	< 9.72	39.9
	20121600153	ERA 0823-11-05.2: 10 µl	9.72	06/15/12	< 9.72	9.975
	20122020003	ERA 0823-11-05.2: 20 µl	9.72	07/26/12	< 9.72	19.95
	20123420072	Abs 071112: 10 µl & ERA 0507-12-06.2: 10 µl	9.72	12/14/12	< 9.72	9.75
	20130320040	ERA 0823-11-05.2: 10 µl & Abs 053112: 10 µl	9.72	02/28/13	< 9.72	9.975
	20130390106	Spex Organics T1120802015: 20 µl & Abs 071112: 20 µl	9.72	02/28/13	< 9.72	19.5
	20131090003	Abs 071112: 20 µl & ERA 0507-12-06.2: 20 µl	9.72	04/26/13	< 9.72	19.5
	20133110111	ERA 0823-11-05.1: 15 µl & Abs 071112: 15 µl	9.72	11/20/13	< 9.72	14.625

Updated 08/31/2015

BQS Organic Blind Sample Program

False Positives & False Negatives

SITAGLIPTIN

Method: LC9017 Testid: 67531LCM56

Link to Individual Chart

False Positive & Negative Listing for SITAGLIPTIN

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20123420072	Abs 071112: 10 µl & ERA 0507-12-06.2: 10 µl	97.3	12/16/12	< 97.3	97.5

Updated 08/31/2015

BQS Organic Blind Sample Program

False Positives & False Negatives

SULFAMETHOXAZOLE

Method: LC9017 Testid: 67454LCM56

Link to Individual Chart

False Positive & Negative Listing for SULFAMETHOXAZOLE

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20123420072	Abs 071112: 10 µl & ERA 0507-12-06.2: 10 µl	26.1	12/14/12	< 26.1	26.5
	20133110111	ERA 0823-11-05.1: 15 µl & Abs 071112: 15 µl	26.1	11/20/13	< 26.1	39.75

Updated 08/31/2015

BQS Organic Blind Sample Program

False Positives & False Negatives

TAMOXIFEN

Method: LC9017 Testid: 68015LCM56

Link to Individual Chart

False Positive & Negative Listing for TAMOXIFEN

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20122230019	Abs 060112: 20 µl & ERA 0507-12-06.1: 20 µl	52.4	08/15/12	< 52.4	106
	20122720046	Abs 053112: 20 µl & ERA 0507-12-06.2: 20 µl	52.4	10/25/12	< 52.4	107
	20122930153	Abs 060112: 10 µl & Spex Organics T1120802015: 10 µl	52.4	10/25/12	< 52.4	53
	20123420072	Abs 071112: 10 µl & ERA 0507-12-06.2: 10 µl	52.4	12/14/12	< 52.4	53.5
	20130590062	ERA 0507-12-06.1: 20 µl & ERA 0507-12-06.2: 20 µl	52.4	03/27/13	< 52.4	107
	20130740022	Abs 053112: 20 µl & Abs 060112: 20 µl	52.4	03/27/13	< 52.4	106
	20132210043	ERA 0507-12-06.1: 15 µl & Abs 060112: 15 µl	52.4	08/18/13	< 52.4	79.5
	20140510045	ERA 0507-12-06.1: 20 µl & ERA 0507-12-06.2: 20 µl	52.4	03/21/14	< 52.4	107

Updated 08/31/2015

BQS Organic Blind Sample Program

False Positives & False Negatives

TEMAZEPAM

Method: LC9017 Testid: 67471LCM56

Link to Individual Chart

False Positive & Negative Listing for TEMAZEPAM

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Positive	20123560094	Abs 053112: 40 µl & ERA 0507-12-06.2: 40 µl	18.4	01/24/13	. 62.8	0

Updated 08/31/2015

BQS Organic Blind Sample Program

False Positives & False Negatives

THEOPHYLLINE

Method: LC9017 Testid: 67494LCM56

Link to Individual Chart

False Positive & Negative Listing for THEOPHYLLINE

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20121040015	ERA 0823-11-05.2: 20 µl	41.5	05/01/12	< 41.5	82.5
	20123420072	Abs 071112: 10 µl & ERA 0507-12-06.2: 10 µl	41.5	12/14/12	< 41.5	41.75
	20132070033	ERA 0823-11-05.2: 15 µl & ERA 0507-12-06.1: 15 µl	41.5	08/02/13	< 41.5	61.875
	20132630004	ERA 0823-11-05.2: 15 µl & Abs 060112: 15 µl	41.5	10/29/13	< 58.2	61.875
	20133110111	ERA 0823-11-05.1: 15 µl & Abs 071112: 15 µl	41.5	11/20/13	< 41.5	62.625
	20133310033	Abs 071112: 20 µl & Abs 053112: 20 µl	41.5	12/05/13	< 83.4	83.5
	20140030015	Abs 071112: 20 µl & ERA 0507-12-06.2: 20 µl	41.5	01/16/14	< 80	83.5
	20140300038	Spex Organics T1120802015: 20 µl & Abs 071112: 20 µl	41.5	02/20/14	< 80	83.5
False Positive	20130100071	ERA 0823-11-05.1: 40 µl & Abs 060112: 40 µl	41.5	01/24/13	. 465	0

Updated 08/31/2015

BQS Organic Blind Sample Program

False Positives & False Negatives

THIABENDAZOLE

Method: LC9017 Testid: 67455LCM56

Link to Individual Chart

False Positive & Negative Listing for THIABENDAZOLE

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20140370080	ERA 0823-11-05.2: 20 µl & Abs 053112: 20 µl	4.1	02/20/14	< 7.8	8.2

Updated 08/31/2015

BQS Organic Blind Sample Program

False Positives & False Negatives

TRIAMTERENE

Method: LC9017 Testid: 67475LCM56

Link to Individual Chart

False Positive & Negative Listing for TRIAMTERENE

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20133110111	ERA 0823-11-05.1: 15 µl & Abs 071112: 15 µl	5.25	11/20/13	< 5.77	7.875

Updated 08/31/2015

BQS Organic Blind Sample Program

False Positives & False Negatives

VALACYCLOVIR

Method: LC9017 Testid: 67507LCM56

Link to Individual Chart

False Positive & Negative Listing for VALACYCLOVIR

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20121040015	ERA 0823-11-05.2: 20 µl	163	05/01/12	< 163	327
	20121390010	ERA 0823-11-05.2: 40 µl	163	06/15/12	< 163	654
	20121600153	ERA 0823-11-05.2: 10 µl	163	06/15/12	< 163	163.5
	20122020003	ERA 0823-11-05.2: 20 µl	163	07/26/12	< 163	327
	20123140091	Abs 071112: 40 µl & ERA 0507-12-06.1: 40 µl	163	11/20/12	< 163	656
	20123420072	Abs 071112: 10 µl & ERA 0507-12-06.2: 10 µl	163	12/14/12	< 163	164
	20130320040	ERA 0823-11-05.2: 10 µl & Abs 053112: 10 µl	163	02/28/13	< 163	163.5
	20130390106	Spex Organics T1120802015: 20 µl & Abs 071112: 20 µl	163	02/28/13	< 163	328
	20131210059	ERA 0823-11-05.2: 40 µl	163	05/03/13	< 163	654
	20132070033	ERA 0823-11-05.2: 15 µl & ERA 0507-12-06.1: 15 µl	163	08/02/13	< 163	245.25
	20132630004	ERA 0823-11-05.2: 15 µl & Abs 060112: 15 µl	163	10/29/13	< 163	245.25
	20133110111	ERA 0823-11-05.1: 15 µl & Abs 071112: 15 µl	163	11/20/13	< 163	246
	20133310033	Abs 071112: 20 µl & Abs 053112: 20 µl	163	12/05/13	< 163	328
	20140030015	Abs 071112: 20 µl & ERA 0507-12-06.2: 20 µl	163	01/16/14	< 163	328
	20140300038	Spex Organics T1120802015: 20 µl & Abs 071112: 20 µl	163	02/20/14	< 163	328
	20140370080	ERA 0823-11-05.2: 20 µl & Abs 053112: 20 µl	163	02/20/14	< 163	327
	20140860101	Abs 071112: 20 µl & Abs 060112: 20 µl	163	04/10/14	< 163	328

Updated 08/31/2015

BQS Organic Blind Sample Program

False Positives & False Negatives

VENLAFAXINE

Method: LC9017 Testid: 67534LCM56

Link to Individual Chart

False Positive & Negative Listing for VENLAFAXINE

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20121040015	ERA 0823-11-05.2: 20 µl	4.48	05/01/12	< 4.48	9.150001
	20140300038	Spex Organics T1120802015: 20 µl & Abs 071112: 20 µl	4.48	02/20/14	< 4.91	9

Updated 08/31/2015

BQS Organic Blind Sample Program

False Positives & False Negatives

WARFARIN

Method: LC9017 Testid: 67457LCM56

Link to Individual Chart

False Positive & Negative Listing for WARFARIN

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20121040015	ERA 0823-11-05.2: 20 µl	6.03	05/01/12	< 6.03	12.05
	20131090003	Abs 071112: 20 µl & ERA 0507-12-06.2: 20 µl	6.03	04/26/13	< 6.03	12
	20133110111	ERA 0823-11-05.1: 15 µl & Abs 071112: 15 µl	6.03	11/20/13	< 6.03	9
False Positive	20133470009	ERA 0823-11-05.1: 15 µl & Abs 060112: 15 µl	6.03	01/16/14	. 0.45	0

Updated 08/31/2015